Difference between revisions of "Plasminogen (TG2)"
m (Plasminogen moved to Plasminogen (TG2)) |
|||
| Line 36: | Line 36: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ki0.pdf ASAView] pdf |
| + | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ki0.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 08:43, 25 July 2007
| Template:Infobox header| Plasminogen (TG2) | |
|---|---|
| Plasminogen (TG2) | |
| Substrate peptide name | Plasminogen (TG2) |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; Secreted |
| Swissprot ID | P00747 |
| Reactive glutamines | Q322 |
| Reactive lysines | K298 |
| Substrate sequence | ENFPCKNLDEN
HTTNSQVRWEY |
| Structure | 1KI0 |
| Surface accessibility | ASAView pdf
ASAView txt |
| Disorder prediction | IUPred |
| Reference | PMID:7629099 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}